Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials

BACKGROUND: We aimed to assess the safety and efficiency of the novel sodium glucose co-transporter 2 (SGLT2) inhibitor in combinations with insulin for type 1 and type 2 diabetes mellitus (T1DM and T2DM). METHODS: We searched Medline, Pubmed, Embase, and the Cochrane Collaboration Library from Janu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yingying, Chen, Shi, Pan, Hui, Zou, Yun, Wang, Bo, Wang, Guixia, Zhu, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457866/
https://www.ncbi.nlm.nih.gov/pubmed/28538386
http://dx.doi.org/10.1097/MD.0000000000006944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457866/
https://www.ncbi.nlm.nih.gov/pubmed/28538386
http://dx.doi.org/10.1097/MD.0000000000006944

Ejemplares similares